Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas
- PMID: 20043716
- DOI: 10.3171/2009.11.FOCUS09216
Using ex vivo proton magnetic resonance spectroscopy to reveal associations between biochemical and biological features of meningiomas
Abstract
Object: The goal in this study was to determine if proton ((1)H) MR spectroscopy can differentiate meningioma grade and is associated with interpretations of biological behavior; the study was performed using ex vivo high-resolution spectra indicating metabolic characteristics.
Methods: Sixty-eight resected tissue samples of meningiomas were examined using ex vivo (1)H MR spectroscopy. Of these meningiomas, 46 were WHO Grade I, 14 were WHO Grade II, and 8 were WHO Grade III. Fifty-nine were primary meningiomas and 9 were recurrences. Invasion of adjacent tissue (dura mater, bone, venous sinus, brain) was found in 32 cases. Thirty-nine meningiomas did not rapidly recur (as defined by expansion on MR imaging within a 5-year follow-up period), whereas rapid recurrence was confirmed in 24 meningiomas, and follow-up status was unknown in 5 cases.
Results: The absolute concentrations of total alanine and creatine were decreased in high-grade compared with low-grade meningiomas, as was the ratio of glycine to alanine (all p < 0.05). Additionally, alanine and the glycine/alanine ratio distinguished between primary and recurrent meningiomas (all p < 0.05). Finally, the absolute concentrations of alanine and creatine, and the glycine/alanine and choline/glutamate ratios were associated with rapid recurrence (p < 0.05).
Conclusions: These data indicate that meningioma tissue can be characterized by metabolic parameters that are not typically identified by histopathological analysis alone. Creatine, glycine, and alanine may be used as markers of meningioma grade, recurrence, and the likelihood of rapid recurrence. These data validate a previous study of a separate group of Grade I meningiomas.
Similar articles
-
Noninvasive evaluation of the malignant potential of intracranial meningiomas performed using proton magnetic resonance spectroscopy.J Neurosurg. 1999 Dec;91(6):928-34. doi: 10.3171/jns.1999.91.6.0928. J Neurosurg. 1999. PMID: 10584837
-
Utilization of glutamate/creatine ratios for proton spectroscopic diagnosis of meningiomas.Neuroradiology. 2007 Feb;49(2):121-7. doi: 10.1007/s00234-006-0167-z. Epub 2006 Nov 4. Neuroradiology. 2007. PMID: 17086406 Clinical Trial.
-
MRS study of meningeal hemangiopericytoma and edema: a comparison with meningothelial meningioma.Oncol Rep. 2012 Oct;28(4):1461-7. doi: 10.3892/or.2012.1919. Epub 2012 Jul 19. Oncol Rep. 2012. PMID: 22824994
-
Long-term surgical outcomes of spinal meningiomas.Spine (Phila Pa 1976). 2012 May 1;37(10):E617-23. doi: 10.1097/BRS.0b013e31824167f1. Spine (Phila Pa 1976). 2012. PMID: 22146282 Review.
-
Biomarkers for differentiating grade II meningiomas from grade I: a systematic review.Br J Neurosurg. 2021 Dec;35(6):696-702. doi: 10.1080/02688697.2021.1940853. Epub 2021 Jun 21. Br J Neurosurg. 2021. PMID: 34148477
Cited by
-
Imaging Characteristics of Meningiomas.Adv Exp Med Biol. 2023;1416:21-33. doi: 10.1007/978-3-031-29750-2_3. Adv Exp Med Biol. 2023. PMID: 37432617
-
Evaluation of Cancer Metabolomics Using ex vivo High Resolution Magic Angle Spinning (HRMAS) Magnetic Resonance Spectroscopy (MRS).Metabolites. 2016 Mar 22;6(1):11. doi: 10.3390/metabo6010011. Metabolites. 2016. PMID: 27011205 Free PMC article. Review.
-
Predicting Consistency of Meningioma by Magnetic Resonance Imaging.J Neurol Surg B Skull Base. 2015 Jun;76(3):225-9. doi: 10.1055/s-0034-1543965. Epub 2015 Jan 21. J Neurol Surg B Skull Base. 2015. PMID: 26225306 Free PMC article.
-
Magnetic resonance spectroscopy for the study of cns malignancies.Prog Nucl Magn Reson Spectrosc. 2021 Feb;122:23-41. doi: 10.1016/j.pnmrs.2020.11.001. Epub 2020 Dec 2. Prog Nucl Magn Reson Spectrosc. 2021. PMID: 33632416 Free PMC article.
-
Use of preoperative magnetic resonance imaging T1 and T2 sequences to determine intraoperative meningioma consistency.Surg Neurol Int. 2011;2:142. doi: 10.4103/2152-7806.85983. Epub 2011 Oct 12. Surg Neurol Int. 2011. PMID: 22059137 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources